Interrelation of the main hormonal markers in patients with metabolic syndrome
DOI:
https://doi.org/10.12775/JEHS.2023.37.01.015Keywords
Metabolic syndrome, hormonal markers, Ghrelin, Leptin, Adiponectin, obesityAbstract
Background. The study of the relationships between the main hormonal markers in patients with metabolic syndrome is relevant due to the growing prevalence of this syndrome in the world. The metabolic syndrome is a complex of risk factors, such as obesity, insulin resistance, hypertension and dyslipidaemia, and is known to significantly increase the risk of developing cardiovascular disease and diabetes.
The aim. The aim is to trace the relationship between hormonal markers of metabolic syndrome and assess their impact on its development.
Materials and methods. The study involved 96 participants from the Ukrainian population, comprising 53 cases of obesity and 43 non-obese individuals (controls), with no significant age and sex differences between the groups.
The hormonal markers investigated included Leptin, Ghrelin, Adiponectin, and Resistin. The determination of serum levels was performed using specific ELISA kits, and correlation analyses were conducted to assess the associations between these markers.
Results and discussion. The correlation analysis revealed a statistically significant close negative association between Ghrelin and Leptin levels (ρ = -0.633, p < 0.001). This implies that as Leptin levels decrease, Ghrelin levels tend to increase. The regression analysis demonstrated that 26.7% of the observed variance in Ghrelin levels could be explained by changes in Leptin levels. A strong negative correlation was observed between Adiponectin and Leptin levels (ρ = -0.818, p < 0.001). This indicates that as Leptin levels decrease, Adiponectin levels tend to increase. The regression analysis suggested that 54.8% of the observed variance in Adiponectin levels could be explained by changes in Leptin levels. The correlation analysis indicated a strong positive association between Resistin and Leptin levels (ρ = 0.776, p < 0.001). As Leptin levels increase, Resistin levels also tend to increase. The regression analysis suggested that 47.5% of the observed variance in Resistin levels could be explained by changes in Leptin levels.
Conclusions. The study reveals significant correlations between hormonal markers in metabolic syndrome patients
References
Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Martín-Rodríguez A, Martínez-Guardado I, Navarro-Jiménez E, Laborde-Cárdenas CC, Tornero-Aguilera JF. The Role of Adipokines in Health and Disease. Biomedicines. 2023:27;11(5):1290. doi: 10.3390/biomedicines11051290.
Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014:8;220(2):T47-59. doi: 10.1530/JOE-13-0339.
Castela I, Morais J, Barreiros-Mota I, Silvestre MP, Marques C, Rodrigues C, Ismael S, Araújo JR, Ângelo-Dias M, Martins C, Borrego LM, Monteiro R, Coutinho SR, Calhau C, Martins C, Faria A, Pestana D, Teixeira D. Decreased adiponectin/leptin ratio relates to insulin resistance in adults with obesity. Am J Physiol Endocrinol Metab. 2023:1;324(2):E115-E119. doi: 10.1152/ajpendo.00273.2022.
Prodan A, Dzhyvak V. Metabolic syndrome: Correlation between main hormones and oxidative stress parameters. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2022:29(2);214-219. https://rjdnmd.org/index.php/RJDNMD/article/view/1134
Wang X, Zhang S, Li Z. Adipokines in glucose and lipid metabolism. Adipocyte. 2023;12(1):2202976. doi: 10.1080/21623945.2023.2202976.
Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab. 2001;12(3):118-22. doi: 10.1016/s1043-2760(00)00362-3.
Akalu Y, Molla MD, Dessie G, Ayelign B. Physiological Effect of Ghrelin on Body Systems. Int J Endocrinol. 2020;25:2020:1385138. doi: 10.1155/2020/1385138.
Prodan A, Dzhyvak, V. Comparative evaluation of different types of bariatric surgery. Journal of Education, Health and Sport. 2022;12(4):186–192. doi:10.12775/JEHS.2022.12.04.016
Ramos-Lobo AM, Donato J Jr. The role of leptin in health and disease. Temperature (Austin). 2017;26:4(3):258-291. doi: 10.1080/23328940.2017.1327003.
Rosenbaum M, Leibel RL. 20 years of leptin: role of leptin in energy homeostasis in humans. J Endocrinol. 2014;223(1):T83-96. doi: 10.1530/JOE-14-0358.
Picó C, Palou M, Pomar CA, Rodríguez AM, Palou A. Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord. 2022;23(1):13-30. doi: 10.1007/s11154-021-09687-5.
Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T, Isenovic ER. Leptin and Obesity: Role and Clinical Implication. Front Endocrinol (Lausanne). 2021;12:585887. doi: 10.3389/fendo.2021.585887.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 A. Prodan, O. Kamyshnyi, V. Dzhyvak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 156
Number of citations: 0
